Skip to main content
Clinical Trials/NCT06322511
NCT06322511
Recruiting
Not Applicable

The Effectiveness of Dialogical Family Guidance in Families With a Child With Neurodevelopmental Disorders

Tampere University1 site in 1 country50 target enrollmentJanuary 2, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Family Dynamics
Sponsor
Tampere University
Enrollment
50
Locations
1
Primary Endpoint
FAFHES
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

This new family intervention, called Dialogical Family Guidance (DFG) is developed to target family needs especially in families with a child with neurodevelopmental disorders. PhD study showed, that this intervention is functioning with this target group. Participants (families) experienced that they got information, guidance to ordinary life and that the DFG-therapists were listening to them and above all, helping with individual problems and questions. DFG include six meetings and professionals need to attend on a 3-day long education before using this intervention.

Detailed Description

Previous studies have highlighted the need for families with a child with neurodevelopmental disorders, to get guidance to daily life, information and also professionals who allow parents to share their own experiences, feelings and questions. Dialogical Family Guidance is developed to offer target families (participants) the help mentioned above. This study is a postdoctoral study to achieve more knowledge and understanding about DFG intervention. This Postdoctoral study is focusing on DFG effectivity offered to families with young children (5-7years). Researchers also want to receive information about DFG effectivity between different units inside and outside the university hospital. Comparation between different units using DFG is one goal with this postdoc study. These results may give researchers deeper understanding when deciding where (university hospital och basic level units) and for whom (childrens age?) DFG intervention is giving the most optimal help.

Registry
clinicaltrials.gov
Start Date
January 2, 2024
End Date
December 31, 2027
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Diana Cavonius-Rintahaka

PhD

Tampere University

Eligibility Criteria

Inclusion Criteria

  • Families with a child with clinical diagnosis within neurodevelopmental ambrella (ADHD, Tourette, Autism disorder, OCD...).
  • the child must be between 4-13 years.

Exclusion Criteria

  • Families who do not understand finnish language (because they can not fill the questionnaires and professionals offering DFG are all finnish speaking). At least one parent needs to talk finnish.
  • Families who are not motivated to receive DFG.
  • Families who do not have a child with neurodevelopmental disorders.

Outcomes

Primary Outcomes

FAFHES

Time Frame: 0 months and 3 months

FAFHES (Family Function, Health, and Social Support-questionnaire). The name of the questionnaire explains the content of this questionnaire that includes three sections: family functionality (19 items), family health (23 items), family support provided by professionals (21 items). Likert scale is used with ranging from 1-6 (1= disagree totally......6=I agree totally).

Secondary Outcomes

  • DFG-questionnaire(3 months)
  • SDQ-p questionnaire (Strengths and difficulties regarding the child)(0 months and 3 months)

Study Sites (1)

Loading locations...

Similar Trials